急性心肌梗死后心源性休克患者的风险分层
该研究基于IABP-SHOCK II试验,通过逐步多变量回归分析开发了一个简易风险评分,用于预测心源性休克患者30天死亡率。评分包含六个变量,分低、中、高三个风险类别,观察到的30天死亡率分别为23.8%、49.2%和76.6%(p < 0.0001);在IABP-SHOCK II注册队列中验证的曲线下面积为0.79,在CardShock试验(n = 137)外部验证的曲线下面积为0.73。结论认为该评分易于计算,与梗死相关心源性休克患者的死亡率强烈相关,可能有助于风险分层和临床决策。
要点
- IABP-SHOCK II风险评分包含年龄>73岁、既往卒中、入院血糖>10.6 mmol/l(191 mg/dl)、入院肌酐>132.6 μmol/l(1.5 mg/dl)、PCI后TIMI血流分级<3级、入院动脉血乳酸>5 mmol/l共六个变量。
- 评分分低危(0-2分)、中危(3或4分)、高危(5-9分)三组,30天死亡率分别为23.8%、49.2%、76.6%(p < 0.0001)。
- 外部验证(CardShock试验,n = 137)中,低、中、高危组短期死亡率分别为28.0%、42.9%、77.3%(p < 0.001),曲线下面积为0.73。
核心结论
- IABP-SHOCK II风险评分可在日常临床实践中轻松计算,并与梗死相关心源性休克患者的死亡率强烈相关。
- 该评分可能有助于对患者短期死亡风险进行分层,从而可能促进临床决策。
研究设计与样本
- 评分通过逐步多变量回归分析从IABP-SHOCK II试验中开发,并在IABP-SHOCK II注册队列和CardShock试验人群(n = 137)中进行验证。
主要发现
- 六个变量为30天死亡率的独立预测因子:年龄>73岁、既往卒中、入院血糖>10.6 mmol/l(191 mg/dl)、入院肌酐>132.6 μmol/l(1.5 mg/dl)、PCI后TIMI血流分级<3级、入院动脉血乳酸>5 mmol/l。
- 每个变量赋1或2分,总分对应三个风险类别:低危(0-2分)、中危(3或4分)、高危(5-9分)。
- 开发队列中观察到的30天死亡率分别为23.8%、49.2%和76.6%(p < 0.0001)。
- IABP-SHOCK II注册队列验证显示良好的区分度,曲线下面积为0.79。
- CardShock试验外部验证(n = 137)显示短期死亡率分别为28.0%(0-2分)、42.9%(3-4分)、77.3%(5-9分;p < 0.001),曲线下面积为0.73;Kaplan-Meier分析显示不同评分类别间死亡率逐步增加(0-2分 vs 3-4分:p = 0.04;0-2分 vs 5-9分:p = 0.008)。
关键数值与推荐
- 评分参数及阈值:年龄>73岁、既往卒中、入院血糖>10.6 mmol/l(191 mg/dl)、入院肌酐>132.6 μmol/l(1.5 mg/dl)、PCI后TIMI血流分级<3级、入院动脉血乳酸>5 mmol/l。
- 风险类别:低危0-2分、中危3或4分、高危5-9分。
临床怎么用
- 作者认为该评分可在日常临床实践中轻松计算,并与梗死相关心源性休克患者的死亡率强烈相关,可能有助于风险分层和临床决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mortality in cardiogenic shock (CS) remains high. Early risk stratification is crucial to make adequate treatment decisions. OBJECTIVES: This study sought to develop an easy-to-use, readily available risk prediction score for short-term mortality in patients with CS, derived from the IABP-SHOCK II (Intraaortic Balloon Pump in Cardiogenic Shock) trial. METHODS: The score was developed using a stepwise multivariable regression analysis. RESULTS: Six variables emerged as independent predictors for 30-day mortality and were used as score parameters: age >73 years, prior stroke, glucose at admission >10.6 mmol/l (191 mg/dl), creatinine at admission >132.6 μmol/l (1.5 mg/dl), Thrombolysis In Myocardial Infarction flow grade <3 after percutaneous coronary intervention, and arterial blood lactate at admission >5 mmol/l. Either 1 or 2 points were attributed to each variable, leading to a score in 3 risk categories: low (0 to 2), intermediate (3 or 4), and high (5 to 9). The observed 30-day mortality rates were 23.8%, 49.2%, and 76.6%, respectively (p < 0.0001). Validation in the IABP-SHOCK II registry population showed good discrimination with an area under the curve of 0.79. External validation in the CardShock trial population (n = 137) showed short-term mortality rates of 28.0% (score 0 to 2), 42.9% (score 3 to 4), and 77.3% (score 5 to 9; p < 0.001) and an area under the curve of 0.73. Kaplan-Meier analysis revealed a stepwise increase in mortality between the different score categories (0 to 2 vs. 3 to 4: p = 0.04; 0 to 2 vs. 5 to 9: p = 0.008). CONCLUSIONS: The IABP-SHOCK II risk score can be easily calculated in daily clinical practice and strongly correlated with mortality in patients with infarct-related CS. It may help stratify patient risk for short-term mortality and might, thus, facilitate clinical decision making. (Intraaortic Balloon Pump in Cardiogenic Shock II [IABP-SHOCK II]; NCT00491036).
引用
- Pöss J, Köster J, Fuernau G, et al. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2017. PMID: 28408020. doi:10.1016/j.jacc.2017.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。